Radiation study for tumors that spread to soft tissue areas
Part of Cancer, Digestive system, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This study looks at how a planned form of palliative radiation therapy treats certain solid cancers that have spread outside the brain to larger soft-tissue areas. It may help shrink tumors and relieve symptoms, but it also asks you to meet specific safety and treatment-timing rules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a biopsy-confirmed solid cancer that has spread (examples include breast, lung, GI, bladder, kidney, melanoma, or soft tissue sarcoma)
- Your doctor is planning palliative radiation to at least one outside-the-brain metastatic site that is at least 5 cm in one direction
- Your body function score is 0 or 1 (you can do most normal activities or light work)
- You cannot be pregnant or breastfeeding
- You cannot have had prior radiation to the same targeted metastatic area
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a special type of radiation to standard palliative radiation helps reduce symptoms like pain, shortness of breath, or bleeding. It's for people with tumors that can't be removed and are large.
This trial studies whether stereotactic (high-precision) radiation given in a few sessions can control rare cancers that have spread to a small number of sites. It aims to help by treating all known spots while keeping side effects manageable.
This trial looks at adding a focused radiation treatment called SBRT to standard care for cancers that have spread to a limited number of spots. It aims to control those spread-out tumors while still using the usual cancer treatment plan.
This Phase 2 study tests whether adding a very focused type of radiation to standard drug treatment can better control metastatic breast cancer. It is for people whose cancer is only progressing in one spot, seen on a PET scan.
This trial tests higher doses of radiation therapy to relieve symptoms from larger tumors that cannot be cured. The goal is to improve symptom control and quality of life.
This trial tests whether treating each spot of cancer that has spread (but only a few spots) with focused radiation can help control breast cancer. It aims to see if this approach can stop the cancer from growing further without needing strong whole-body treatments right away.
Hear when a new Lobular Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.